Breaking News Headlines Today | Ground News

See every side of every news story

The Progress image

News from The Progress

Clearfield, United States

The Progress’s aggregated media bias check is Center. This is a score we've assigned by combining the media bias ratings of a Center rating from Media Bias/Fact Check .

Is The Progress credible or reliable? Our Factuality score answers both of those questions. When it comes to The Progress, we’ve assigned a High factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about The Progress

Where is The Progress located?Clearfield, United StatesThe Progress's Website The Progress's Twitter

Media Bias Ratings

Average Bias Rating:

Center

Center

byMedia Bias/Fact Check

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top The Progress News

MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics

Shenzhen · Shenzhen

MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics

57% Center coverage: 35 sources

SHENZHEN, China, Sept. 14, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet…See the Story

National Grid and Emerald AI Announce Strategic Partnership to Demonstrate AI Power Flexibility in the UK

Artificial Intelligence · United Kingdom

National Grid and Emerald AI Announce Strategic Partnership to Demonstrate AI Power Flexibility in the UK

52% Center coverage: 23 sources

National Grid and Emerald AI are partnering to show how AI data centres can support a smarter, more flexible grid.A UK-first live trial is planned for late 2025 on a grid connected data centre using Emerald AI's platform and cutting-edge…See the Story

Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

Hong Kong City · Hong Kong

Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

48% Center coverage: 23 sources

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225). The trial will evaluate cadonilimab, Akeso's first-in-class PD-1/CTLA-4…See the Story

Breaking News Topics Related to The Progress